0000950144-01-507049.txt : 20011008 0000950144-01-507049.hdr.sgml : 20011008 ACCESSION NUMBER: 0000950144-01-507049 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20010919 GROUP MEMBERS: NEVON INC GROUP MEMBERS: NEVON VENTURES LIMITED PARTNER SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NOVEN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000815838 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 592767632 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-40243 FILM NUMBER: 1740449 BUSINESS ADDRESS: STREET 1: 11960 SW 144TH ST CITY: MIAMI STATE: FL ZIP: 33186 BUSINESS PHONE: 3052535099 MAIL ADDRESS: STREET 1: 11960 SW 144TH STREET CITY: MIAMI STATE: FL ZIP: 33185 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SABLOTSKY STEVEN CENTRAL INDEX KEY: 0001037762 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 11960 SW 144 ST CITY: MIAMI STATE: FL ZIP: 33186 BUSINESS PHONE: 3052535099 MAIL ADDRESS: STREET 1: 11960 SW 144 ST CITY: MIAMI STATE: FL ZIP: 33186 SC 13D/A 1 g70699sc13da.txt NOVEN PHARMACEUTICALS, INC. 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* NOVEN PHARMACEUTICALS, INC. --------------------------- (Name of Issuer) COMMON STOCK, $.0001 PAR VALUE ------------------------------ (Title of Class of Securities) 670009-10-9 ----------- (Cusip Number) STEVEN SABLOTSKY 3305 WEST SPRING MOUNTAIN ROAD, SUITE 60, LAS VEGAS, NEVADA 89102 ----------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) JULY 10, 2001 ----------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ] NOTE: Schedules filed in paper format shall include a signed original and five copies of this schedule, including all exhibits. See ss. 240.13d-7 for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. (Continued on following page(s)) Page 1 2 ---------------------------------- --------------------------- CUSIP NO. 670009-10-9 13D PAGE 2 ---------------------------------- --------------------------- --------- ---------------------------------------------------------------------- 1 Names of Reporting Persons I.R.S. Identification No. of Above Person STEVEN SABLOTSKY --------- ---------------------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group (a) [X] (b) [ ] --------- ---------------------------------------------------------------------- 3 SEC Use Only --------- ---------------------------------------------------------------------- 4 Source of Funds OO --------- ---------------------------------------------------------------------- 5 Check Box if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) [ ] --------- ---------------------------------------------------------------------- 6 Citizenship or Place of Organization USA -------------------------- ------ ---------------------------------------------- NUMBER OF 7 Sole Voting Power SHARES 1,068,314 BENEFICIALLY ------ ----------------------------------------------- OWNED BY 8 Shared Voting Power EACH REPORTING 0 PERSON WITH ------ ---------------------------------------------- 9 Sole Dispositive Power 1,068,314 ------ ---------------------------------------------- 10 Shared Dispositive Power 0 --------- ---------------------------------------------------------------------- 11 Aggregate Amount Beneficially Owned by Each Reporting Person 1,068,314 --------- ---------------------------------------------------------------------- 12 Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares [ ] --------- ---------------------------------------------------------------------- 13 Percent of Class Represented by Amount in Row (11) 4.8% --------- ---------------------------------------------------------------------- 14 Type of Reporting Person IN --------- ---------------------------------------------------------------------- Page 2 3 ---------------------------------- --------------------------- CUSIP NO. 670009-10-9 13D PAGE 3 ---------------------------------- --------------------------- --------- ---------------------------------------------------------------------- 1 Names of Reporting Persons I.R.S. Identification No. of Above Person NEVON VENTURES LIMITED PARTNERSHIP --------- ---------------------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group (a)[X] (b)[ ] --------- ---------------------------------------------------------------------- 3 SEC Use Only --------- ---------------------------------------------------------------------- 4 Source of Funds OO --------- ---------------------------------------------------------------------- 5 Check Box if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) [ ] --------- ---------------------------------------------------------------------- 6 Citizenship or Place of Organization NEVADA -------------------------- ------ ---------------------------------------------- NUMBER OF 7 Sole Voting Power SHARES 0 BENEFICIALLY ------ ---------------------------------------------- OWNED BY 8 Shared Voting Power EACH REPORTING 694,100 PERSON WITH ------ ---------------------------------------------- 9 Sole Dispositive Power 0 ------ ---------------------------------------------- 10 Shared Dispositive Power 694,100 --------- ---------------------------------------------------------------------- 11 Aggregate Amount Beneficially Owned by Each Reporting Person 694,100 --------- ---------------------------------------------------------------------- 12 Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares [ ] --------- ---------------------------------------------------------------------- 13 Percent of Class Represented by Amount in Row (11) 3.1% --------- ---------------------------------------------------------------------- 14 Type of Reporting Person PN --------- ---------------------------------------------------------------------- Page 3 4 ---------------------------------- --------------------------- CUSIP NO. 670009-10-9 13D PAGE 4 ---------------------------------- --------------------------- --------- ---------------------------------------------------------------------- 1 Names of Reporting Persons I.R.S. Identification No. of Above Person NEVON, INC. --------- ---------------------------------------------------------------------- 2 Check the Appropriate Box if a Member of a Group (a)[X] (b)[ ] --------- ---------------------------------------------------------------------- 3 SEC Use Only --------- ---------------------------------------------------------------------- 4 Source of Funds OO --------- ---------------------------------------------------------------------- 5 Check Box if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) [ ] --------- ---------------------------------------------------------------------- 6 Citizenship or Place of Organization USA -------------------------- ------ ---------------------------------------------- NUMBER OF 7 Sole Voting Power SHARES 0 BENEFICIALLY ------ ---------------------------------------------- OWNED BY 8 Shared Voting Power EACH REPORTING 694,100 PERSON WITH ------ ---------------------------------------------- 9 Sole Dispositive Power 0 ------ ---------------------------------------------- 10 Shared Dispositive Power 694,100 --------- ---------------------------------------------------------------------- 11 Aggregate Amount Beneficially Owned by Each Reporting Person 694,100 --------- ---------------------------------------------------------------------- 12 Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares [ ] --------- ---------------------------------------------------------------------- 13 Percent of Class Represented by Amount in Row (11) 3.1% --------- ---------------------------------------------------------------------- 14 Type of Reporting Person CO --------- ---------------------------------------------------------------------- Page 4 5 AMENDMENT NO. 2 TO SCHEDULE 13D Item 1. SECURITY AND ISSUER. This Amendment No. 2 to Schedule 13D is filed jointly by Steven Sablotsky, Nevon Ventures Limited Partnership (the "Partnership") and Nevon, Inc. (collectively, the "Reporting Persons") with respect to the Common Stock, $.0001 par value (the "Common Stock"), of Noven Pharmaceuticals, Inc. (the "Issuer"). Item 2. IDENTITY AND BANKGROUND On July 10, 2001, Mr. Sablotsky resigned from the Board of Directors of the Issuer, and Mr. Sablotsky is no longer a director or an officer of the Issuer. Mr. Sablotsky's principal business address is 3305 West Spring Mountain Road, Suite 60, Las Vegas, Nevada 89102. Item 5. INTEREST IN SECURITIES OF THE ISSUER. Item 5 is amended and restated in its entirety as follows: As of July 10, 2001, the Reporting Persons beneficially owned the following Shares: AMOUNT OF SHARES PERCENTAGE OF NAME BENEFICIALLY OWNED (D) CLASS (1) ---- ---------------------- ------ Steven Sablotsky(2) 1,068,314 4.8% Nevon Ventures Limited Partnership 694,100 3.1% Nevon, Inc. 694,100 3.1% -------------------- (1) Based on 22,271,742 shares of Common Stock issued and outstanding as reported on the Issuer's Form 10-Q for the quarterly period ended March 31, 2001 filed on May 14, 2001 and assumes the exercise of options to acquire 26,844 Shares exercisable within 60 days of July 10, 2001. (2) Includes 694,100 Shares held by the Partnership, a limited partnership of which Mr. Sablotsky is the sole limited partner. The Partnership is controlled by its sole general partner, Nevon, Inc. Mr. Sablotsky is the sole shareholder, director and officer of Nevon, Inc. Also includes 347,370 Shares owned directly by Mr. Sablotsky and options to purchase 26,844 Shares owned directly by Mr. Sablotsky and exercisable within 60 days of July 10, 2001. The Partnership shares the power to vote or dispose of the Shares beneficially owned by it with Nevon, Inc. and Mr. Sablotsky. Nevon, Inc., in its capacity as the general partner of the Partnership, has the power to vote or direct the vote of these Shares or to dispose or direct the disposition of the Shares for the Partnership. Nevon, Inc. will be deemed the beneficial owner of the Shares owned by the Partnership by virtue of this relationship to the Page 5 6 Partnership. Mr. Sablotsky, in his capacity as the sole shareholder, a director and an officer of Nevon, Inc., the general partner of the Partnership, will be deemed the beneficial owner of all Shares owned by the Partnership by virtue of his power to vote or direct the vote of the Shares or to dispose or direct the disposition of the Shares owned by the Partnership. None of the Reporting Persons engaged in any transactions in the Common Stock during the past 60 days. Item 7. MATERIAL TO BE FILED AS EXHIBITS. 1. Joint Filing Agreement. Page 6 7 SIGNATURES After reasonable inquiry and to the best of the undersigned's knowledge and belief, the undersigned certify that the information set forth in this Statement is true, complete and correct. Date: September 19, 2001 /s/ STEVEN SABLOTSKY --------------------------------------- Steven Sablotsky NEVON VENTURES LIMITED PARTNERSHIP, a Nevada limited partnership By: NEVON, INC., a Nevada corporation and its General Partner Date: September 19, 2001 By: /s/ STEVEN SABLOTSKY ----------------------------------- Steven Sablotsky, President NEVON, INC., a Nevada corporation Date: September 19, 2001 By: /s/ STEVEN SABLOTSKY ----------------------------------- Steven Sablotsky, President Page 7 EX-99.1 3 g70699ex99-1.txt JOINT FILING AGREEMENT 1 EXHIBIT 1 JOINT FILING AGREEMENT The undersigned hereby agree that this Amendment No. 2 to the Schedule 13D filed by us with respect to the Common Stock of Noven Pharmaceuticals, Inc. is filed on behalf of each of us. Date: September 19, 2001 /s/ STEVEN SABLOTSKY --------------------------------------- Steven Sablotsky NEVON VENTURES LIMITED PARTNERSHIP, a Nevada limited partnership By: NEVON, INC., a Nevada corporation and its General Partner Date: September 19, 2001 By: /s/ STEVEN SABLOTSKY ----------------------------------- Steven Sablotsky, President NEVON, INC., a Nevada corporation Date: September 19, 2001 By: /s/ STEVEN SABLOTSKY ----------------------------------- Steven Sablotsky, President